Antioxidant Status and Biomarkers of Oxidative Stress in Dogs with Lymphoma

Background: Oxidative stress might play a role in carcinogenesis, as well as impacting morbidity and mortality of veterinary cancer patients. The purpose of this study was to evaluate antioxidant concentrations and biomarkers of oxidative stress in dogs with newly diagnosed lymphoma before treatment and once in remission, with comparison with healthy controls.
Hypothesis: Dogs with lymphoma have increased oxidant and reduced antioxidant concentrations compared with healthy controls, and that these abnormalities normalize once remission is achieved.
Animals: Seventeen dogs with lymphoma and 10 healthy controls.
Methods: Prospective, observational study. Measures of oxidative stress [malondialdehyde and total isoprostanes (isoP)] and antioxidants [α-tocopherol, γ-tocopherol, oxygen radical absorbance capacity (ORAC), and glutathione peroxidase (GSHPx)] were assessed in dogs with newly diagnosed lymphoma before treatment compared with healthy control dogs. The same parameters were measured in the dogs with lymphoma on week 7 of the chemotherapy protocol when all dogs were in remission.
Results: At baseline, dogs with lymphoma had significantly lower α-tocopherol ( P <.001) and γ-tocopherol ( P = .003) but higher GSHPx ( P = .05), ORAC ( P = .001), and isoP ( P < .001) compared with healthy controls. In the dogs with lymphoma, α-tocopherol concentrations were higher ( P = .005) and ascorbic acid were lower ( P = .04) after treatment.
Conclusions and Clinical Importance: Results suggest that dogs with lymphoma have alterations in oxidant and antioxidant concentrations and that the status of some of these biomarkers normalize after remission. Further studies are warranted to determine whether antioxidant interventions to correct these are beneficial in the treatment of canine lymphoma.     

Rock crab predation of juvenile sea scallops: the functional response and its implications for bottom culture

The functional response describes how consumption rate of individual predators changes as prey density changes, and can have important implications for the bottom culture of scallops. We examined (i) the functional response of rock crabs (Cancer irroratus) preying on juvenile sea scallops (Placopecten magellanicus); (ii) the effect of substrate type and scallop size on the functional response; and (iii) the underlying behavioural mechanisms of observed functional responses. Specifically, we quantified predation rate and behaviours, such as the proportion of time spent searching for prey, encounter rate between predators and prey and the outcomes of encounters, when individual rock crabs were offered a range of scallop density (2–50 or 11–111 scallops m⁻²) and two size classes of scallops (∼ ∼25 and ∼ ∼35 mm shell height) on two different substrate types (“glass-bottom” and “granule”). We found that crab predation rate on small juvenile scallops increased at a decelerating rate with prey density to a plateau at high prey density on both substrates, indicating a hyperbolic (type II) functional response. Crab predation rate on large juvenile scallops was independent of prey density (i.e., no functional response evident), suggesting that crabs were at their satiation level. Prey density did not influence any behaviour except encounter rate on small juvenile scallops, which increased as prey density increased. Substrate type influenced crab predation: maximum predation rate of crabs on small juvenile scallops and encounter rate with either size of juvenile scallops was lower on granule than on glass-bottom. Our results in the laboratory suggest that crabs could potentially be swamped if scallops are seeded at a high density in the field. However, many factors in the field may influence the functional response. For example, the presence of multiple prey types may lead to sigmoid functional responses, while the presence of many crab individuals may lead to aggregation of crabs in areas of high prey density.     

Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol

BACKGROUND: Treatment of lymphoma in dogs by long-term chemotherapy has favorable results. However, the efficacy of short-term, maintenance-free treatment protocols on remission and survival times in dogs has not been determined. HYPOTHESIS: That treatment using a 12-week chemotherapy protocol would be associated with satisfactory treatment outcome in dogs with lymphoma. ANIMALS: 77 dogs with histologically or cytologically confirmed diagnosis of lymphoma. METHODS: Prospective clinical trial in which dogs were treated with a 12-week chemotherapy protocol consisting of L-asparaginase, vincristine, cyclophosphamide, doxorubicin, and prednisolone. RESULTS: Complete remission rate was 76.3%. Multivariate logistic regression analysis revealed that clinical substage (P = .006) and immunophenotype (P = .003) had a significant influence on the likelihood of a dog achieving complete remission. Median duration of first complete remission was 243 days (range 19-1,191 days). The 6-month, 1-year, and 2-year remission rates were 68%, 28%, and 16%, respectively. In the multivariate analysis of patient variables, immunophenotype (P = .022) revealed a significant influence on first remission duration. Toxicosis was mild with the exception of 1 treatment-associated death. CONCLUSIONS AND CLINICAL IMPORTANCE: In this group of dogs the 12-week maintenance-free chemotherapy protocol was well tolerated and had satisfactory results.     

Atmospheric forcing drives recruitment variation in the Dungeness crab (Cancer magister), revisited

For 12 yr (1997–2001, 2006–2012) daily abundance of Cancer magister megalopae was measured in Coos Bay, Oregon. Before 2007 from 2000 to 80 000 megalopae were caught annually. In 2007, catch jumped and has since varied from 164 000 to 2.3 million. The step change in catch size appears related to a shift to negative Pacific Decadal Oscillation (PDO) values. Late season catches, which cannot be due to local spawning, are negatively correlated to the PDO, suggesting that these megalopae derive from north of the California Current. During periods of lower and higher catches, annual returns of megalopae were significantly negatively correlated to the day of the year of the spring transition and positively correlated to the amount of upwelling during the settlement season. The size of the Oregon commercial catch lagged 4 yr to allow for growth of recruits into the fishery is set by the number of returning megalopae; the relationship is parabolic. At lower returns, the population is recruitment limited, but at higher returns, density‐dependent effects predominate and set the commercial catch. Lagged commercial catches in Washington and Northern and Central California were also related to the number of megalopae returning to Coos Bay, suggesting that the forces causing variation in larval success are coast wide. If high return rates are due to a PDO regime shift, then for years to decades the commercial catch may be set by density‐dependent effects following settlement and the huge numbers of returning megalopae may impact benthic community structure.     

Doxorubicin induces stemness of mouse TNBC 4T1 cells through Stat3-Oct-4/CD44 signaling pathway

AIM:To investigate the stemness of mouse triple-negative breast cancer (TNBC) 4T1 cells induced by doxorubicin (DOX) and the underlying mechanism. METHODS:The 4T1 cells and MDA-MB-468 cells were treated with DOX at different concentrations (0, 0.05, 0.1 and 0.5 μmol/L) for 24 h, and the shape and viability of the cells were observed. The concentration of DOX at 0.1 μmol/L was chosen as the optimal concentration for the following experiments. The 4T1 cells and MDA-MB-468 cells resistant to DOX were established by continuous stimulation with DOX for 4 weeks, and named as 4T1-DOX and MDA-MB-468-DOX. Sphere formation assay was used to detect the stemness of 4T1 cells and MDA-MB-468 cells. The expression of CD133 was observed by immunofluorescence staining. The expression of CD44 was analyzed by flow cytometry. The protein levels of Stat3, phosphorylated Stat3 (p-Stat3) and Oct-4 were determined by Western blot. RESULTS:The sphere formation ability of the 4T1-DOX cells was stronger than that of the 4T1 control cells. The 4T1-DOX cells expressed high levels of the stemness markers CD133 and CD44 as compared with the 4T1 cells (P<0.05). Furthermore, the 4T1-DOX cells exhibited enhanced activation of Stat3 (p-Stat3) and increased expression of Oct-4 (P<0.05), while the expression of total Stat3 had no obvious variation. In addition, when activation of Stat3 was inhibited by WP1066, the protein levels of p-Stat3, Oct-4 and CD44 were down-regulated (P<0.05). Furthermore, inhibition of Stat3 phosphorylation reduced the sphere formation ability of the 4T1-DOX cells (P<0.05). CONCLUSION:DOX induces the stemness of mouse TNBC 4T1 cells through Stat3-Oct-4 signaling pathway.     

Association between ovarihysterectomy and feline mammary carcinoma

The etiopathogenesis of feline mammary carcinoma is not well understood. Although putative, risk factors include breed, reproductive status, and regular exposure to progestins. An association between age at ovarihysterectomy (OHE) and mammary carcinoma development has not been established. Therefore, a case-control study was performed to determine the effects of OHE age, breed, progestin exposure, and parity on feline mammary carcinoma development. Cases were female cats diagnosed with mammary carcinoma by histological examination of mammary tissue. Controls were female cats not diagnosed with mammary tumors selected from the same biopsy service population. Controls were frequency matched to cases by age and year of diagnosis. Questionnaires were sent to veterinarians for 308 cases and 400 controls. The overall questionnaire response rate was 58%. Intact cats were significantly overrepresented (odds ratio [OR] 2.7, confidence interval [CI] = 1.4-5.3, P < .001) in the mammary carcinoma population. Cats spayed prior to 6 months of age had a 91% reduction in the risk of mammary carcinoma development compared with intact cats (OR 0.9, CI = 0.03-0.24). Those spayed prior to 1 year had an 86% reduction in risk (OR 0.14, CI = 0.06-0.34). Parity did not affect feline mammary carcinoma development, and too few cats had progestin exposure to determine association with mammary carcinoma. Results indicate that cats spayed before 1 year of age are at significantly decreased risk of feline mammary carcinoma development.     

Concentration of lipocalin region of collagen XXVII alpha 1 in the serum of dogs with hemangiosarcoma

Background: Hemangiosarcoma (HSA) is a common malignancy of dogs with characteristic early, aggressive metastasis. Diagnosis of HSA is challenging because of lack of sensitive and specific diagnostic tests. Hypothesis: Specific proteins that are increased in serum of dogs with HSA might represent useful biomarkers of the disease. Animals: Thirty‐four dogs with HSA and 42 healthy dogs from the Ontario Veterinary College Teaching Hospital. Methods: This case‐control study compared serum proteins in dogs with HSA and healthy dogs. Proteins were separated by 2‐dimensional difference gel electrophoresis and identified by liquid chromatography and tandem mass spectrometry. Results: Western blot analysis showed that serum collagen XXVII peptide concentration in serum of dogs with large metastatic HSA burdens (1,488, 231–3,754 DU; median, minimum‐maximum); was, on average, 9.5‐fold higher than in healthy dogs (156; 46–2,101 DU). While concentrations for dogs with osteosarcomas (678; 124–3,251 DU), lymphomas (423; 92–2,777 DU), carcinomas (1,022; 177–3,448 DU), and inflammatory disease were also increased, values were consistently lower than those for HSA. Receiver operating characteristic curves revealed an estimated area under the curve of 83% for HSA cases whereas areas for other neoplastic and nonneoplastic diseases were nondiscriminatory. Serum collagen XXVII peptide concentration before splenectomy (1,350; 1,156–1,929 DU) was reduced after tumor removal (529; 452–562 DU) and chemotherapy but increased in 2 dogs with tumor recurrence (511–945 DU; 493–650 DU). Conclusions and Clinical Importance: Collagen XXVII peptide might be useful for diagnosis and monitoring of advanced HSA.     

Medical Uses Of Essential Fatty Acids (EFAs)

Abstract— In 1956 Sinclair suggested that abnormalities of EFA metabolism might be the basis of many of the unsolved diseases which particularly affect Western societies, notably cardiovascular and inflammatory disorders and cancer. Dismissed as a crank for about 25 years, Sinclair is now being recognised as a percipient pioneer. Recent evidence for the roles of EFAs in cancer, vascular disease, diabetic complications and inflammatory disorders such as atopic eczema and arthritis is discussed.
Resumen  En 1956, Sinclair sugirió que la causa de algunos enfermedades que afectaban al mundo occidental podría ser abnormalidades del metabolismo de los EFA, en particular, enfermedades cardiovasculares, inflamatorias y cancer. Por un periodo de 25 años sus teorías fueron rechazadas, sin embargo hoy se le cdrisidera un pionero en la materia. El reciente descubrimiento del papel de los EFA en cancer, enfermedades cardiovasculares, complicaciones de la diabetes y disórdenes inflamatorios (como arthritis y eczema), se discute en éste artículo.